Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities of continuing operations:
Net income (loss)	$ (4,877,380)	$ (6,045,659)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	824,241	844,294
Amortization of debt discount	628,423	141,278
Common stock issued for financing costs	2,250	17,499
Common stock issued in exchange for fees and services	753,170	956,705
Deferred taxes	(48,544)	(8,240)
Stock-based compensation	461,118	2,376,835
Changes in operating assets and liabilities:
Accounts receivable	(232,540)	(245,867)
Inventory	(212,259)	(16,458)
Prepaid expenses and other current assets	657,538	(200,558)
Other assets	(33,256)	(18,882)
Accounts payable	(28,742)	(74,775)
Accrued liabilities	(230,081)	318,547
Advanced payments and deferred revenues	(64,396)	406,721
Income taxes payable and other noncurrent liabilities	(18,564)	(36,689)
Related party payables	105,005	315,520
Net cash provided by (used in) operating activities	(1,865,601)	(1,269,729)
Cash flows from investing activities:
Cash acquired in acquisition of business	0	182
Purchase of fixed assets	(581,975)	(155,420)
Net cash provided by (used in) investing activities	(581,975)	(155,238)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs	608,717	0
Proceeds from exercise of common stock purchase warrants, net of issuance costs	61,500	1,511,000
Proceeds from issuance of convertible debentures	1,914,702	0
Repayments of senior secured promissory notes	(10,000)	0
Proceeds from issuance of senior, secured promissory notes	0	32,000
Repayments of convertible debentures	(75,000)	(125,000)
Net cash provided by (used in) financing activities	2,499,919	1,418,000
Effect of exchange rates on cash and cash equivalents	144,381	(24,708)
Net increase (decrease) in cash and cash equivalents	196,724	(31,675)
Cash and cash equivalents at beginning of period	436,869	443,494
Cash and cash equivalents at end of period	633,593	436,869
Supplemental disclosure of cash flow information:
Cash paid for interest	277,149	0
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued related to acquisition of business	52,500	0
Common stock issued related to acquisition of intangible assets	0	60,000
Common stock issued for financing costs incurred in connection with convertible and promissory notes	1,003,621	0
Common stock issued in connection with long term service contracts	72,000	0
Common stock issued to reduce convertible and promissory notes payable	30,000	500,000
Common stock issued to reduce accounts payable and other accrued liabilities	1,321,376	33,000
Contingent purchase consideration	0	362,500
Debt issued related to acquisition of a business	0	1,000,000
Discount for beneficial conversion features on convertible debentures	$ 801	$ 60,123